Home » Topics » BioWorld Science

BioWorld Science
RSS

5alpha-Reductase inhibitors from Kyowa Hakko

July 12, 1996

Selective alpha1A-adrenoceptor antagonists with multiple indications

July 12, 1996

NovoSeven hits U.K. market

July 12, 1996

TxA2 antagonists/TxA2 synthase inhibitors from Fujisawa

July 12, 1996

Bristol-Myers Squibb's Pravachol cleared by FDA for new indication

July 12, 1996

Teijin's prostaglandin MCP-1/MCAF inhibitors

July 12, 1996

Smooth muscle cell proliferation inhibitors described by American Home Products

July 12, 1996

NEP inhibition research findings

July 12, 1996

Endothelin antagonists part of Fujisawa's pipeline

July 12, 1996

Na+/K+-ATPase inhibitors revealed by Sigma-Tau

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...